Cargando…
Vaccines in Gastrointestinal Malignancies: From Prevention to Treatment
Gastrointestinal (GI) malignancies are some of the most common and devastating malignancies and include colorectal, gastric, esophageal, hepatocellular, and pancreatic carcinomas, among others. Five-year survival rates for many of these malignancies remain low. The majority presents at an advanced s...
Autores principales: | Chudasama, Rani, Phung, Quan, Hsu, Andrew, Almhanna, Khaldoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231997/ https://www.ncbi.nlm.nih.gov/pubmed/34199248 http://dx.doi.org/10.3390/vaccines9060647 |
Ejemplares similares
-
Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update
por: DeCarli, Kathryn, et al.
Publicado: (2022) -
Targeted therapies for gastroesophageal cancers
por: Hsu, Andrew, et al.
Publicado: (2020) -
Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
por: Hsu, Andrew, et al.
Publicado: (2020) -
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
por: Almhanna, Khaldoun, et al.
Publicado: (2009) -
Editorial for the series on gastric and gastroesophageal cancer treatment in 2020
por: Almhanna, Khaldoun
Publicado: (2020)